Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

Seth Flaxman, Swapnil Mishra, Axel Gandy et al. · Nature · 2020 · 3.8K citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +11

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael et al. · New England Journal of Medicine · 2020 · 3.5K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley et al. · The Lancet · 2020 · 2.6K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2

Steven Sanche, Yen Ting Lin, Chonggang Xu et al. · Emerging infectious diseases · 2020 · 1.6K citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao, Linlin Bao, Haiyan Mao et al. · Science · 2020 · 1.5K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15